AI Agent Development for Medical Device Manufacturers

AI agent development for medical device manufacturers automates QMS workflows and post-market surveillance, cutting manual documentation time by 60 to 80 percent. It is the practice of building software agents that route regulated tasks, flag anomalies, and require human sign-off before any record is finalized.

QServices is a Microsoft Solutions Partner that has shipped production AI agents for regulated industries since 2010. Learn more about our industry solutions across healthcare, financial services, and manufacturing.

Why Medical Device Manufacturers Need AI Agents Right Now

The FDA's Quality Management System Regulation (QMSR), effective February 2026, aligns US device quality requirements with ISO 13485:2016 for the first time. According to the FDA's QMSR guidance, the rule covers all Class II and Class III device establishments registered with the agency and sets stricter expectations for electronic record integrity, audit trails, and documented change management. If your quality system was built around the pre-2026 QSR framework, it needs updating.

EU MDR post-market clinical follow-up requirements have separately forced manufacturers to collect and analyze surveillance data at volumes that manual processes cannot handle. A mid-sized manufacturer with 10 to 20 device families can generate hundreds of PSUR updates, CAPA records, and Technical File revisions per year. Quality teams commonly report spending 35 to 45 percent of their time on documentation and routing work that requires oversight but not expert judgment.

The math is direct. A three-person quality team spending 40 percent of their time on documentation tasks costs roughly $150,000 per year in loaded labor. An AI agent handling that work costs a fraction of that figure and runs continuously. The constraint is building agents that satisfy Part 11 and ISO 13485 audit requirements. That is the engineering problem we solve at QServices.

What We Build for Medical Device Clients

We build four types of agents for medical device manufacturers, each targeting a documented pain point in your quality or regulatory workflow:

• QMS Document Automation Agent. Generates draft SOPs, CAPAs, and change control records from structured input. Cuts drafting time by 60 percent. HITL checkpoint: a Quality Manager reviews and signs off in Veeva Vault or MasterControl before any document enters the official record.
• Post-Market Surveillance Agent. Pulls complaint data from SAP or Oracle EBS, classifies events against FDA MDR and EU MDR reportability thresholds, and drafts initial PSUR sections. HITL checkpoint: a Regulatory Affairs specialist reviews every reportability determination before any submission is filed.
• Regulatory Submission Drafter. Converts internal technical files into 510(k) or EU Technical Documentation draft sections, reducing submission prep from months to weeks. HITL checkpoint: the Head of Regulatory approves each section before it leaves the organization.
• ERP-QMS Integration Agent. Bridges your legacy ERP (SAP or Oracle EBS) with your QMS (Veeva Vault or MasterControl) without replacing either system. Syncs material records, supplier qualification status, and batch data in real time. HITL checkpoint: any data exception routes to a human review queue before the record is written.

Every agent ships with a Part 11-compliant audit log. QServices does not deploy agents to medical device clients without it.

How an AI Agent Development Engagement Actually Works

Most first-agent projects for medical device manufacturers run 8 to 12 weeks. Multi-agent platforms run longer. Here is the step-by-step process:

1. Weeks 1 to 2: Discovery and HITL Design. We map the target workflow in detail: who owns each step, what data moves between systems, and where a bad AI decision creates a regulatory event. We define every Human-in-the-Loop checkpoint before writing a single line of code. This phase is not optional; skipping it is the most common reason medical device AI projects fail validation.
2. Weeks 3 to 4: Data and Integration Audit. We audit your systems (SAP, Veeva Vault, MasterControl) for data quality and API availability. We document which integrations use standard connectors and which need custom middleware, and we price the difference upfront so there are no surprises at week eight.
3. Weeks 5 to 7: Agent Build and Internal Testing. We build the agent on Azure AI Foundry with Power Automate for workflow orchestration. We run evaluation tests against real, de-identified workflow samples. We do not test with synthetic data in regulated environments.
4. Weeks 8 to 9: Validation Protocol. We prepare IQ/OQ documentation and run validation testing in a staging environment that mirrors your production QMS configuration. This documentation is written to satisfy a Part 11 audit, not just for internal use.
5. Weeks 10 to 12: Pilot and Handoff. The agent runs in parallel with the existing manual process for two to four weeks. Your team compares outputs and flags discrepancies. We remediate before go-live, then provide monitoring dashboards and a 90-day support window.

What This Costs

AI agent development for medical device manufacturers typically runs $50,000 to $300,000, depending on scope. A single well-defined agent covering one workflow and one primary integration lands in the $50,000 to $120,000 range. A multi-agent platform covering document automation, post-market surveillance, and submission drafting with full validation documentation runs $150,000 to $300,000.

What drives cost up:

• Multiple regulated systems to integrate (SAP plus Veeva Vault plus MasterControl)
• Full IQ/OQ/PQ validation documentation across multiple agents
• Third-party compliance review for ISO 13485 or EU MDR audit scope
• Part 11 audit log implementation across multiple agents with different data sources
• Post-market surveillance scope spanning both FDA MDR and EU MDR reportability rules

What keeps cost down:

• Starting with one well-scoped workflow rather than automating everything at once
• Existing API access in your QMS platform (Veeva Vault and MasterControl both have REST APIs)
• Clean, structured data in your ERP, which reduces integration complexity significantly
• Reusing Azure AI Foundry components from our prior regulated-industry projects

See our full AI agent development cost guide for detailed breakdowns by scope, integration count, and validation requirements.

Three Things Medical Device Buyers Usually Get Wrong

1. Planning validation as a project phase rather than a design constraint.

Most teams build the agent first and ask "how do we validate this?" at the end. That approach forces expensive rework. FDA 21 CFR Part 11 requirements for electronic records mean the audit trail, access controls, and change management process must be designed from the start. We run a validation design session in week one, before any development begins. Teams that skip this typically add four to eight weeks of rework at the end, and sometimes cannot achieve Part 11 compliance without rebuilding the agent architecture entirely.

2. Assuming the QMS vendor handles the AI integration.

Veeva Vault and MasterControl are excellent platforms, but their native AI features are not designed for custom agent workflows specific to your device class and CAPA process. A VP of Quality who expects the QMS vendor to supply an out-of-the-box agent for their 510(k) submission drafting workflow will be disappointed. Custom agents on Azure AI Foundry give you full control over the data, the model behavior, and the HITL checkpoints. Your QMS vendor does not provide that.

3. Starting post-market surveillance automation before fixing upstream data quality.

Post-market surveillance agents are at the top of every quality team's request list. They are also the most data-dependent. If complaint records in SAP are incomplete, duplicated, or inconsistently coded, the agent produces unreliable classifications at exactly the step where a mistake has regulatory consequences. Our recommendation: start with document automation, where inputs are more structured, and address surveillance data quality in parallel. An AI agent cannot compensate for bad source data.

Recent Work With Clients in Regulated Industries

Our first published medical device case study is in progress for 2026. The closest published examples of our AI agent work in high-stakes, regulated environments are below. Both use the same Azure AI Foundry and Microsoft Copilot Studio stack we deploy for medical device QMS work.

The Smart PM engagement used Azure AI Foundry, Power Automate, and Azure AI Search to automate a structured document-to-action workflow, producing real-time dashboards from data previously captured manually. The Melegacy project demonstrates our Microsoft Copilot Studio capability in a regulated data environment with external API integrations and user-level access controls. Both reflect the architecture we apply to medical device QMS and post-market surveillance agents.

To discuss your device class, quality system, and regulatory obligations, see our AI agent development service page or contact our team.

How Long Does AI Agent Development Take for a Medical Device Manufacturer?

A first production agent for a medical device manufacturer takes 8 to 12 weeks from kick-off to go-live, including HITL design, integration work, and IQ/OQ validation documentation. Projects with multiple system integrations or full PQ validation suites run toward 12 weeks. Multi-agent platforms covering QMS automation, post-market surveillance, and regulatory submission drafting typically run 6 to 9 months total. QServices is a Microsoft Solutions Partner led by CEO Sahil Kataria and CTO Rohit Dabra, with direct experience in Azure AI Foundry deployments for regulated industries.